(NP (NP (NP-COOD (NP (NN Tyrosine) (NN kinase)) (CC and) (NP (JJ cAMP-dependent) (NN protein) (NN kinase))) (NNS activities)) (PP (IN in) (NP (JJ CD40-activated) (JJ human) (NN B) (NNS lymphocytes))) (. .))
(S (ADVP (FW In) (FW vitro)) (, ,) (NP-SBJ-8 (JJ human) (NN B) (NNS lymphocytes)) (VP (VBP undergo) (NP (JJ long-term) (NN proliferation)) (SBAR-TMP (WHADVP-10 (WRB when)) (S (NP-SBJ-9 (-NONE- *-8)) (VP (VBN activated) (NP (-NONE- *-9)) (PP (IN through) (NP (NP (NN CD40)) (, ,) (NP (NP (DT a) (NN protein)) (VP (VBN expressed) (NP (-NONE- *)) (PP (IN on) (NP (PRP$ their) (NN cell) (NN surface))))))) (ADVP (-NONE- *T*-10)))))) (. .))
(S (NP-SBJ (NP (DT The) (NN nature)) (PP (IN of) (NP (NP-11 (JJ CD40-dependent) (NNS signals)) (PP (IN in) (NP (VBG proliferating) (JJ fresh) (JJ human) (ADJP (JJ Epstein-Barr) (JJ virus-negative)) (NN B) (NNS lymphocytes)))))) (VP (VBZ is) (ADVP-TMP (RB currently)) (ADJP-PRD (JJ unknown))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP-SBJ-12 (DT a) (JJ CD40-dependent) (NN B) (NN cell) (NN culture) (NN system)) (VP (VBD was) (VP (VBN used) (NP (-NONE- *-12)) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB examine) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (JJ different) (NN signal) (NN transduction) (NNS elements))))))))) (. .))
(S (NP-SBJ (NP (NP (NP (NN Protein) (NN kinase) (NN C)) (PRN (-LRB- -LRB-) (NP (NN PKC)) (-RRB- -RRB-))) (NN depletion)) (VP (VBN generated) (NP (-NONE- *)) (PP (IN by) (NP (DT a) (JJ long-term) (NN phorbol) (CD 12) (NN myristate) (NN 13-acetate) (NN treatment))))) (VP (VBD had) (NP (JJ weak) (NNS effects)) (PP (IN on) (NP (NN proliferation)))) (. .))
(S (ADVP (RB Rather)) (, ,) (NP-SBJ-14 (NN tyrosine) (NN phosphorylation)) (VP (VBD was) (VP (VBN shown) (S (NP-SBJ-15 (-NONE- *-14)) (VP (TO to) (VP (VB be) (VP (ADVP (RB directly)) (VBN involved) (NP-16 (-NONE- *-15)) (PP (IN in) (S (NP-SBJ (-NONE- *-16)) (VP (VBG mediating) (NP (JJ CD40-dependent) (NNS signals))))))))))) (. .))
(S (NP-SBJ-17 (NP (DT The) (NN use)) (PP (IN of) (NP (DT the) (ADJP (NP (NP (NN protein) (NN tyrosine) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN PTK)) (-RRB- -RRB-))) (JJ -specific)) (NN inhibitor) (NN herbimycin) (NN A)))) (ADVP (RB dramatically)) (VP (VBD decreased) (NP (JJ cellular) (NN proliferation)) (PP (IN without) (S (NP-SBJ (-NONE- *-17)) (VP (VBG altering) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (NP (DT the) (JJ human) (NN immunodeficiency) (NN virus-1) (JJ long) (JJ terminal) (NN repeat)) (PRN (-LRB- -LRB-) (NP (NN HIV-1) (NN LTR)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NN promoter)) (ADJP (RB largely) (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (JJ nuclear) (NN factor) (NN kappa) (NN B)) (PRN (-LRB- -LRB-) (NP NF- (NN kappa) (NN B)) (-RRB- -RRB-))))))))))))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ-18 (DT the) (ADJP (NP (JJ cAMP-dependent) (NN protein) (NN kinase)) (JJ specific)) (NN inhibitor) (NN H-89)) (ADVP (RB totally)) (VP (VBD inhibited) (NP (NN HIV-1) (NN LTR) (NN activity)) (PP (IN at) (NP (NP (DT a) (NN concentration)) (NP (QP (RB as) (JJ low) (IN as) (CD 100)) (NN nM)))) (PP (IN without) (S (NP-SBJ (-NONE- *-18)) (VP (VBG affecting) (NP (JJ cellular) (NN proliferation)))))) (. .))
(S (NP-SBJ (NP-COOD (NP (NP (JJ Electrophoretic) (NN mobility) (NN shift) (NN assay)) (PRN (-LRB- -LRB-) (NP (NN EMSA)) (-RRB- -RRB-))) (CC and) (NP (NN supershift) (NN assay))) (VP (VBG using) (NP (NP (DT an) (NN NF-kappa) (NN B) (NN binding) (NN sequence)) (PP (IN from) (NP (DT the) (NN kappa) (JJ light) (NN chain)))) (PP (IN as) (NP (DT a) (NN probe))))) (, ,) (VP (VBD revealed) (SBAR (IN that) (S (NP-SBJ-COOD (CC both) (NP (NP (NNS p65)) (PRN (-LRB- -LRB-) (NP (NN RelA)) (-RRB- -RRB-))) (CC and) (NP (NN c-Rel))) (VP (VBD were) (ADJP-PRD (JJ present) (PP (IN in) (NP (JJ CD40-stimulated) (NN B) (NNS cells)))))))) (. .))
(S (SBAR (IN While) (S (NP-SBJ (NN PKC) (NN depletion)) (VP (VBD did) (RB not) (VP (VB alter) (NP (DT the) (NN NF-kappa) (NN B) (NN level)))))) (, ,) (NP-SBJ (NP (NN treatment)) (PP (IN of) (NP (NN B) (NNS lymphocytes))) (PP (IN with) (NP-COOD (NP (NN H-89)) (CC or) (NP (NN herbimycin) (NN A))))) (VP (VBD provoked) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (DT the) (NN NF-kappa) (NN B) (NN level))))) (. .))
(S (NP-SBJ (DT These) (NNS observations)) (VP (VBP establish) (NP (NP (DT the) (NN importance)) (PP (IN of) (NP (NP (JJ different) (NN signal) (NN transducing) (NNS pathways)) (VP (VBG leading) (PP (TO to) (NP (NP (NN CD40) (NN activation)) (PP (IN of) (NP (NN B) (NNS lymphocytes)))))))))) (. .))
